CohnReznick, a professional services firm, added Doug Schmid as a partner in its CFO advisory practice, where he will have particular focus on leading the growth of its life sciences practice. He will be based in the firm’s Boston office.
Schmid brings experience advising growth-stage and public companies on complex financial and strategic initiatives, including capital markets transactions, IPO readiness, mergers and acquisitions, technical accounting and finance transformation. His experience spans biotechnology, biopharmaceuticals, medical technology and life sciences services.
Combining advisory leadership with Fortune 500 operating experience, Schmid works closely with executive leadership teams to navigate critical business milestones. His expertise includes commercial readiness, public company reporting, revenue recognition and inventory accounting, as well as building advisory capabilities for emerging and publicly traded companies.
“Doug brings a valuable combination of advisory and industry experience to our growing Life Sciences practice,” Swami Venkat, partner – CFO advisory at CohnReznick, said. “His understanding of the financial and operational challenges facing life sciences companies, from early-stage growth through public company reporting, will help expand our capabilities and support clients as they navigate important business milestones.”
Prior to joining CohnReznick, Schmid held leadership roles at a leading professional services firm and a global medical technology company. He began his career at a Big Four accounting firm. He holds bachelor’s and master’s degrees in accountancy from Bentley University.
